<DOC>
	<DOC>NCT01229397</DOC>
	<brief_summary>The study aims to evaluate the immunogenicity of a single full (0.5 mL) dose and a 0.25 mL 2-dose regime of Inflexal V in unprimed children aged 6 - &lt;36 months, using the EMA guideline for the re-registration of the seasonal influenza vaccine in adults (aged ≥18 ≤60 years) as reference.</brief_summary>
	<brief_title>Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V</brief_title>
	<detailed_description />
	<criteria>Healthy male and female children Aged ≥6 to &lt;36 months on Day 1 Born at a gestational age ≥37 weeks Written informed consent No previous influenza vaccination Acute respiratory infection or other acute disease Acute febrile illness (≥38.0 °C) Past vaccination with an influenza vaccine, including vaccination against the influenza strain A/California/7/2009 (H1N1)like virus Laboratoryconfirmed infection with any influenza strain, including the pandemic influenza strain H1N1 (A/California/7/2009 (H1N1)like virus) Known hypersensitivity to any vaccine component Known history of egg protein allergy or severe atopy Known blood coagulation disorder Chronic (longer than 14 days) administration of immunosuppressants or other immunemodifying drugs within 6 months before the first dose of the study vaccine, incl. oral corticosteroids in dosages of ≥0.5 mg/kg/d prednisolone or equivalent for ≥14 days (inhaled or topical steroids are allowed) Known immunodeficiency (including leukemia, cancer, HIV seropositivity) Investigational medicinal product received in the past 3 months (90 days) Treatment with immunoglobulins or blood transfusion(s) received in the past 3 months (90 days) Vaccination with the MMR vaccine in the past 4 weeks, or planned within the study period Participation in another clinical trial Child or legal charge of the investigator or an employee at the study site, or living in the same household as the investigator/employee and/or dependent on the investigator/employee Suspected noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Virus</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Immunisation</keyword>
</DOC>